Related Experiment Video
Updated: Sep 25, 2025

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast Cancer
Alexandra C Apple1, Cutter A Lindbergh1,2, Susan M Landau3,4
1University of California San Francisco, Department of Neurology, Memory and Aging Center, San Francisco, CA, USA.
Patients receiving chemotherapy for breast cancer show less memory improvement over time compared to controls. This reduced practice effect may indicate cognitive difficulties post-treatment.
Area of Science:
- Neuroscience
- Oncology
- Cognitive Psychology
Background:
- Breast cancer treatments can impact cognition, but long-term cognitive changes across different treatment types are not well understood.
- The integrity of the hippocampal-prefrontal cortex network is implicated in cognition, yet its predictive role in longitudinal cognitive performance requires further investigation.
Purpose of the Study:
- To investigate longitudinal cognitive trajectories in early-stage breast cancer patients undergoing adjuvant therapy compared to healthy controls.
- To examine how different adjuvant cancer treatments influence cognitive performance over time.
- To explore the relationship between baseline brain structure (hippocampal and prefrontal volumes) and longitudinal cognitive changes.
Main Methods:
- A prospective trial involving 69 early-stage breast cancer patients and 12 controls.
- Longitudinal cognitive assessments (episodic memory, executive functioning, processing speed) at four time points over 24 months.
- Baseline structural MRI to measure hippocampal and prefrontal cortex volumes in a subset of participants.
Main Results:
- Significant group-by-time interactions were observed for memory performance, with patients receiving chemotherapy or chemotherapy plus hormone therapy showing the least improvement.
- No significant effects of treatment group on the relationship between time and processing speed or executive functioning.
- No differences in baseline hippocampal or prefrontal volumes between groups, and no significant interaction effects involving baseline regional volumes on cognition.
Conclusions:
- Early-stage breast cancer patients treated with chemotherapy or chemotherapy plus hormone therapy exhibit diminished benefits from practice effects on memory tests compared to controls.
- The loss of longitudinal practice effect in memory performance may serve as a novel and clinically significant indicator of cognitive challenges experienced by patients post-treatment.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Related Concept Videos
Longitudinal Research
Longitudinal Studies
Cancer Survival Analysis
Traumatic Memory
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...